Esophagogastric varices develop in 50-60% of patients with liver cirrhosis, and 30% of them have one episode of variceal hemorrhage within two years of variceal diagnosis. The aim of the paper was to present the latest attitudes in the treatment of esophagogastric varices. Literature review. Prevention of first bleeding from esophageal varices (EV) involves the use of non-selective beta blockers (NSBB) or carvedilol, while in case of their intolerance or contraindications for their use, endoscopic band ligation (EBL) should be performed. In acute variceal bleeding, endoscopy should be performed, preferably within 12 hours of the presentation of the bleeding, and EBL should be applied. In case of refractory hemorrhage (about 20%), repeated endoscopy and hemostasis or balloon tamponade, self-expanding metal stent (SEMS), transjugular intrahepatic portosystemic shunt (TIPS) and surgical therapy are required. Bleeding from gastric varices (GV) is less common than bleeding from EV but is significantly more severe with higher mortality and more frequent treatment failure. The therapy of choice is the application of cyanoacrylate (CYA), which can be applied under endoscopic ultrasonography (EUS) control. In the trial is the administration of coil injections with or without CYA. In the secondary prophylaxis of bleeding from EV, NSBB should be used in combination with EBL. In the secondary prophylaxis of bleeding from cardiofundal varices, the approach is individual. The therapy of choice for the primary prevention of bleeding from EV is NSBB, while the combined therapy (NSBB and EBL) is for the secondary prophylaxis of bleeding. CYA is the therapy of choice for GI bleeding. Refractory variceal hemorrhage requires the application of many therapeutic modalities.
References
1.
Maimone S, Saffioti F, Filomia R, Alibrandi A, Isgrò G, Calvaruso V, et al. Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS). Digestive Diseases and Sciences. 2019;64(5):1335–45.
2.
Kovacs TOG, Jensen DM. Varices. Clinics in Liver Disease. 2019;23(4):625–42.
3.
Nett A, Binmoeller KF. Endoscopic Management of Portal Hypertension–related Bleeding. Gastrointestinal Endoscopy Clinics of North America. 2019;29(2):321–37.
4.
Dai C. Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage: A meta-analysis. World Journal of Gastroenterology. 2015;21(8):2534.
5.
Karsan HA, Morton SC, Shekelle PG, Spiegel BMR, Suttorp MJ, Edelstein MA, et al. Combination Endoscopic Band Ligation and Sclerotherapy Compared with Endoscopic Band Ligation Alone for the Secondary Prophylaxis of Esophageal Variceal Hemorrhage: A Meta-Analysis. Digestive Diseases and Sciences. 2005;50(2):399–406.
6.
Djurdjevic, Janosevic, Dapcevic, Vukcevic, Djordjevic, Svorcan, et al. Combined Ligation and Sclerotherapy Versus Ligation Alone for Eradication of Bleeding Esophageal Varices: A Randomized and Prospective Trial. Endoscopy. 1999;31(4):286–90.
7.
Singh P, Pooran N, Indaram A, Bank S. Combined Ligation and Sclerotherapy Versus Ligation Alone for Secondary Prophylaxis of Esophageal Variceal Bleeding: A Meta-Analysis. American Journal of Gastroenterology. 2002;97(3):623–9.
8.
Lo G ho, Lai K hung, Cheng J shiung, Lin C ku, Huang J sheng, Hsu P i, et al. The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: A prospective, randomized trial. Hepatology. 1998;28(2):391–5.
9.
Hou MC, Chen WC, Lin HC, Lee FY, Chang FY, Lee SD. A new “sandwich” method of combined endoscopic variceal ligation and sclerotherapy versus ligation alone in the treatment of esophageal variceal bleeding: A randomized trial. Gastrointestinal Endoscopy. 2001;53(6):572–8.
10.
Cheng YS, Pan S, Lien GS, Suk FM, Wu MS, Chen JN, et al. Adjuvant sclerotherapy after ligation for the treatment of esophageal varices: A prospective, randomized long-term study. Gastrointestinal Endoscopy. 2001;53(6):566–71.
11.
Grgov S, Stamenkovic P. Does sclerotherapy of remnant little oesophageal varices after endoscopic ligation have impact on the reduction of recurrent varices?: Prospective study. Srpski arhiv za celokupno lekarstvo. 2011;139(5–6):328–32.
12.
Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: Rational basis, available treatments and future options. Journal of Hepatology. 2008;48:S68–92.
13.
Escorsell À, Pavel O, Cárdenas A, Morillas R, Llop E, Villanueva C, et al. Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial. Hepatology. 2016;63(6):1957–67.
14.
Shao XD, Qi XS, Guo XZ. Esophageal Stent for Refractory Variceal Bleeding: A Systemic Review and Meta-Analysis. BioMed Research International. 2016;2016:1–10.
15.
Bai Z, Wang R, Cheng G, Ma D, Ibrahim M, Chawla S, et al. Outcomes of early versus delayed endoscopy in cirrhotic patients with acute variceal bleeding: a systematic review with meta-analysis. European Journal of Gastroenterology & Hepatology. 2021;33(1S):e868–76.
16.
Selzner M, Tuttle-Newhall JE, Dahm F, Suhocki P, Clavien PA. Current Indication of A Modified Sugiura Procedure in The Management of Variceal Bleeding. Journal of the American College of Surgeons. 2001;193(2):166–73.
17.
Deng Z cheng, Jiang W zhu, Chen L, Tang X dong, Liu S hai. Laparoscopic VS. Open splenectomy and oesophagogastric devascularisation for liver cirrhosis and portal hypertension: A retrospective cohort study. International Journal of Surgery. 2020;80:79–83.
18.
Luo H ping, Zhang Z guo, Long X, Liu F long, Chen X ping, Zhang L, et al. Combined Laparoscopic Splenectomy and Esophagogastric Devascularization versus Open Splenectomy and Esophagogastric Devascularization for Portal Hypertension due to Liver Cirrhosis. Current Medical Science. 2020;40(1):117–22.
19.
Rodge GA, Goenka U, Goenka MK. Management of Refractory Variceal Bleed in Cirrhosis. Journal of Clinical and Experimental Hepatology. 2022;12(2):595–602.
20.
Garcia-Pagán JC, Barrufet M, Cardenas A, Escorsell À. Management of Gastric Varices. Clinical Gastroenterology and Hepatology. 2014;12(6):919-928.e1.
21.
Gubler C, Bauerfeind P. Safe and successful endoscopic initial treatment and long-term eradication of gastric varices by endoscopic ultrasound-guided Histoacryl (N-butyl-2-cyanoacrylate) injection. Scandinavian Journal of Gastroenterology. 2014;49(9):1136–42.
22.
Bick BL, Al-Haddad M, Liangpunsakul S, Ghabril MS, DeWitt JM. EUS-guided fine needle injection is superior to direct endoscopic injection of 2-octyl cyanoacrylate for the treatment of gastric variceal bleeding. Surgical Endoscopy. 2019;33(6):1837–45.
23.
Bhat YM, Weilert F, Fredrick RT, Kane SD, Shah JN, Hamerski CM, et al. EUS-guided treatment of gastric fundal varices with combined injection of coils and cyanoacrylate glue: a large U.S. experience over 6 years (with video). Gastrointestinal Endoscopy. 2016;83(6):1164–72.
24.
Orloff MJ, Hye RJ, Wheeler HO, Isenberg JI, Haynes KS, Vaida F, et al. Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis. Surgery. 2015;157(6):1028–45.
25.
CHEUNG J, ZEMAN M, Van ZANTEN SV, TANDON P. Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices. Alimentary Pharmacology & Therapeutics. 2009;30(6):577–88.
26.
Thiele M, Krag A, Rohde U, Gluud LL. Meta‐analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices. Alimentary Pharmacology & Therapeutics. 2012;35(10):1155–65.
27.
Puente A, Hernández‐Gea V, Graupera I, Roque M, Colomo A, Poca M, et al. Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review. Liver International. 2014;34(6):823–33.
28.
Sharma M, Singh S, Desai V, Shah VH, Kamath PS, Murad MH, et al. Comparison of Therapies for Primary Prevention of Esophageal Variceal Bleeding: A Systematic Review and Network Meta‐analysis. Hepatology. 2019;69(4):1657–75.
29.
Nusrat S. Cirrhosis and its complications: Evidence based treatment. World Journal of Gastroenterology. 2014;20(18):5442.
30.
Garcia‐Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis. Hepatology. 2017;65(1):310–35.
31.
Yue X, Wang Z, Li J, Guo X, Zhang X, Li S, et al. Esophageal variceal ligation plus sclerotherapy vs. ligation alone for the treatment of esophageal varices. Frontiers in Surgery. 9.
32.
Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, Classification and Natural History of Gastric Varices: A Long–Term Follow–Up Study in 568 Portal Hypertension Patients. Hepatology. 1992;16(6):1343–9.
33.
Mishra SR, Sharma BC, Kumar A, Sarin SK. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: A randomized controlled trial. Journal of Hepatology. 2011;54(6):1161–7.
34.
Biecker E. Portal hypertension and gastrointestinal bleeding: Diagnosis, prevention and management. World Journal of Gastroenterology. 2013;19(31):5035.
35.
Ding NS, Nguyen T, Iser DM, Hong T, Flanagan E, Wong A, et al. Liver stiffness plus platelet count can be used to exclude high‐risk oesophageal varices. Liver International. 2016;36(2):240–5.
36.
Robic MA, Procopet B, Métivier S, Péron JM, Selves J, Vinel JP, et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study. Journal of Hepatology. 2011;55(5):1017–24.
37.
Paternostro R, Reiberger T, Bucsics T. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease. World Journal of Gastroenterology. 2019;25(3):308–29.
38.
Portal Hypertension VII. 2022.
39.
Gralnek IM, Camus Duboc M, Garcia-Pagan JC, Fuccio L, Karstensen JG, Hucl T, et al. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2022;54(11):1094–120.
40.
de Franchis R. Introduction: Baveno I to Baveno VI.... and Beyond. Portal Hypertension VI. 2016. p. 3–7.
41.
Pallio S, Melita G, Shahini E, Vitello A, Sinagra E, Lattanzi B, et al. Diagnosis and Management of Esophagogastric Varices. Diagnostics. 13(6):1031.
42.
Villanueva C, Sapena V, Lo GH, Seo YS, Shah HA, Singh V, et al. Stratified efficacy of first -line therapy to prevent first variceal bleeding according to previous decompensation of cirrhosis. A competing-risk meta-analyses of individual participant data. Journal of Hepatology. 2022;77:S625–6.
43.
Funakoshi N, Duny Y, Valats JC, Ségalas-Largey F, Flori N, Bismuth M, et al. Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding. Annals of Hepatology. 2012;11(3):369–83.
44.
Reiberger T, Ulbrich G, Ferlitsch A, Payer BA, Schwabl P, Pinter M, et al. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut. 2013;62(11):1634–41.
45.
Tian S, Li R, Guo Y, Jia X, Dong W. <p>Carvedilol vs endoscopic band ligation for the prevention of variceal bleeding: a meta-analysis</p> Therapeutics and Clinical Risk Management. Volume 15:191–200.
46.
Hammond DA, Lam SW, Rech MA, Smith MN, Westrick J, Trivedi AP, et al. Balanced Crystalloids Versus Saline in Critically Ill Adults: A Systematic Review and Meta-analysis. Annals of Pharmacotherapy. 2020;54(1):5–13.
47.
Veitch AM, Radaelli F, Alikhan R, Dumonceau JM, Eaton D, Jerrome J, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update. Gut. 2021;70(9):1611–28.
48.
Dasa O, Pepine CJ, Pearson TA. Aspirin in Primary Prevention: What Changed? A Critical Appraisal of Current Evidence. The American Journal of Cardiology. 2021;141:38–48.
49.
Eisenberg MJ, Richard PR, Libersan D, Filion KB. Safety of Short-Term Discontinuation of Antiplatelet Therapy in Patients With Drug-Eluting Stents. Circulation. 2009;119(12):1634–42.
50.
Huaringa-Marcelo J, Huaman MR, Brañez-Condorena A, Villacorta-Landeo P, Pinto-Ruiz DF, Urday-Ipanaqué D, et al. Vasoactive Agents for the Management of Acute Variceal Bleeding: A Systematic Review and Meta-analysis. Journal of Gastrointestinal and Liver Diseases. 30(1):110–21.
51.
Yan P, Tian X, Li J. Is additional 5-day vasoactive drug therapy necessary for acute variceal bleeding after successful endoscopic hemostasis? Medicine. 2018;97(41):e12826.
52.
Lee S, Saxinger L, Ma M, Prado V, Fernández J, Kumar D, et al. Bacterial infections in acute variceal hemorrhage despite antibiotics—a multicenter study of predictors and clinical impact. United European Gastroenterology Journal. 2017;5(8):1090–9.
53.
Chang TS, Tsai YH, Lin YH, Chen CH, Lu CK, Huang WS, et al. Limited effects of antibiotic prophylaxis in patients with Child–Pugh class A/B cirrhosis and upper gastrointestinal bleeding. PLOS ONE. 15(2):e0229101.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
